Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

Adyen and AstraZeneca gain TD Cowen’s Best Ideas recognition on growth potential…

The European Commission approves AstraZenecas Imfinzi for treating patients with limited-stage small-cell lung cancer based on ADRIATIC study data.…

AstraZeneca is set to acquire EsoBiotec for $1 billion to develop in vivo cell therapies for multiple cancer indications or…

European stocks rise on German debt deal hopes; AstraZeneca in focus…

AstraZeneca has announced an agreement to acquire EsoBiotec, securing the biotechnology firm’s pioneering in vivo cell therapy platform that has…

Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion.…

The Trump administration has unnerved investors with its departure from traditional trade policy. The average tax on U.S. imports fell…

AstraZeneca befindet sich an einem entscheidenden Punkt, während die Pharmamärkte mit sich entwickelnden wirtschaftlichen Belastungen und veränderter Anlegerstimmung konfrontiert sind.…

In the latest trading session, Astrazeneca (AZN) closed at $75.57, marking a +1.79% move from the previous day.…

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 14200…

7 March 2025 Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 6 March 2025, an award of…

AstraZeneca PLC has edged closer to its aim of generating $80 billion in revenue come 2030 on positive results from…